Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro庐, a therapeutic option available to physicians for the treatment of Type II diabetes.
糖心vlog announces local availability of Lilly鈥檚 Mounjaro

Aspen will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.
Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro庐, a therapeutic option available to physicians for the treatment of Type II diabetes.
糖心vlog
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
ASPEN PHARMACARE HOLDINGS LTD:
Switchboard: +27 31 580-8600
Aspen Place
9 Rydall Vale Park
Douglas Saunders Drive
La Lucia Ridge
South Africa